Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Hospira, Inc. (NY: HSP)
35.01 USD  -0.17 (-0.48%)
Streaming Delayed Price  /  Updated: 9:55 AM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Hospira, Inc.
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
38 39 Next >
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Hospira, Inc.
January 13, 2012
from Business Wire News Releases
Biosimilars: The Next Big Thing
January 13, 2012
As a large number of branded biopharmaceuticals/biologics are slated to lose patent protection in the US and other markets, generic companies like Hospira, Inc. (NYSE:HSP), Teva Pharmaceuticals... Read More
category RHHBY , TEVA , External Research , and 9 more.
from DailyMarkets.com
Invitation 2012 IR Global Rankings
January 12, 2012
Registration of North American and European Companies begins next week Read More
from PR Newswire
Raymond James Downgraded Four Medical Instruments & Supplies Stocks
January 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7073191 for the full story. Read More
from StreetInsider.com News Articles
Raymond James Downgrades Hospira (HSP) to Market Perform
January 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7072178 for the full story. Read More
from StreetInsider.com News Articles
Hospira Close to 50 Day Moving Average
January 09, 2012
New York, January 9th (TradersHuddle.com) - Shares of Hospira, Inc. ( NYSE:HSP ) closed the trading day at $30.14 close to its 50 day moving average currently set at $30.12. Hospira's price action is... Read More
from TradersHuddle.com
Hospira (HSP) Enrolls First Patient in Biosimilar EPO Phase III
January 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7068662 for the full story. Read More
from StreetInsider.com News Articles
Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
January 09, 2012
-- Follows Successful Phase I Trial Results Last Year -- Read More
from PR Newswire
Doctors pressure Hospira over U.S. execution drug
January 05, 2012
LONDON, Jan 6 (Reuters) - An international group of 25 doctors demanded on Friday that U.S.-based Hospira take action to prevent its muscle relaxant drug pancuronium being used for executions in the... Read More
category companyNews
from Reuters: Company News
Durect Corp (DRRX) Reports Top-line Data from BESST Phase III Trial Doesn't Meet Statistical Significance
January 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7061767 for the full story. Read More
from StreetInsider.com News Articles
DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
January 05, 2012
Conference call to be held January 6 at 8:30 a.m. ET Read More
from PR Newswire
Hospira Upped To Neutral
January 05, 2012
We recently upgraded our rating on Hospira, Inc. (NYSE:HSP) from Underperform to Neutral with a target price of $33.00. Hospira is facing continued manufacturing problems at its Rocky Mountain... Read More
category External Research , Contributor , LLY , and 5 more.
from DailyMarkets.com
CORRECTING and REPLACING Glancy Binkow & Goldberg LLP Announces That a Class Action Lawsuit Against Hospira, Inc. Has Been Filed and the Lead Plaintiff Deadline is January 20, 2012
January 04, 2012
from Business Wire News Releases
Hospira (HSP) Down 0.2%, Sees 4x Average Call Volume
December 30, 2011
Hospira (NYSE: HSP) opened at $30.51. So far today, the stock has hit a low of $30.37 and a high of $30.63. HSP is now trading at $30.55, down $0...(Click the story link or go to... Read More
category HSP
from MarketIntelligenceCenter.com
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Hospira, Inc.
December 29, 2011
from Business Wire News Releases
Harwood Feffer LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Hospira Inc.
December 27, 2011
from Business Wire News Releases
Ligand (LGND) Unit Enters $3M Captisol Supply Agreement with Hospira (HSP)
December 27, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7042743 for the full story. Read More
from StreetInsider.com News Articles
Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
December 22, 2011
from PR Newswire
ICU Medical, Inc. Extends Two Distribution Agreements With Hospira, Inc.
December 22, 2011
from GlobeNewswire News Releases
EU puts squeeze on drug supplies for U.S. executions
December 20, 2011
BRUSSELS, Dec 20 (Reuters) - The European Union on Tuesday strengthened export controls on drugs that can be used to administer the death penalty, putting a further squeeze on a supply shortage that... Read More
category companyNews
from Reuters: Company News
Bernstein Cuts Hospira (HSP) to Market Perform
December 19, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7030046 for the full story. Read More
from StreetInsider.com News Articles
Hospira (HSP) Trading Up 0.5%, Sees 2x Average Options Volume
December 19, 2011
Hospira (NYSE: HSP) opened at $28.61. So far today, the stock has hit a low of $28.28 and a high of $29.20. HSP is now trading at $29.06, up $0.14 (0.48%). The stock hit its 52...(Click the story link... Read More
category HSP
from MarketIntelligenceCenter.com
Stock Futures Point to Muted Open
December 19, 2011
First look... Stocks pointed to a lukewarm open Monday, as investors wade through news overseas of Kim Jong Il's death and await developments out of Europe. Fears of the eurozone debt crisis and... Read More
category MA,NFLX,SLB,AMGN,PM,BBT,BAX,CVC,HSP
from MarketIntelligenceCenter.com
UBS Starts Hospira (HSP) at Sell; Itching to Get Involved, But Still Early
December 15, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7023125 for the full story. Read More
from StreetInsider.com News Articles
New Ratings (APKT, ALNY, RDEA, CPHD, FST, HSP, LIFE, NOA)
December 15, 2011
New York, December 15th (TradersHuddle.com) – Following are some of the new analyst ratings before the market open. Research Firms Initiate: Acme Packet (<a href=. Read More -- Read More
from TradersHuddle.com
Hospira Upside Looming?
December 14, 2011
New York, December 14th (TradersHuddle.com) - Shares of Hospira, Inc. ( NYSE:HSP ) ended the trading session flat by $0 or 0% from its previous close. Hospira's price action formed what is considered... Read More
from TradersHuddle.com
Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
December 14, 2011
from PR Newswire
Saxena White P.A. Files a Securities Fraud Class Action Against Hospira, Inc.
December 09, 2011
from Marketwired News Releases
Barclays Maintains an 'Equalweight' on Hospira (HSP); What Could A Consent Decree Mean?
December 08, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7006893 for the full story. Read More
from StreetInsider.com News Articles
Investor Alert: Kahn Swick & Foti, LLC and Partner Former Louisiana Attorney General Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Lawsuit Against Hospira, Inc. -- HSP
December 07, 2011
from GlobeNewswire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
38 39 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here